ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
ALX ONCOLOGY HOLDINGS reports 2022 executive compensation
By ExecPay News
Published: April 24, 2023
ALX ONCOLOGY HOLDINGS reported fiscal year 2022 executive compensation information on April 24, 2023.
In 2022, three executives at ALX ONCOLOGY HOLDINGS received on average a compensation package of $2.5M, a 61% decrease compared to previous year.
Average pay of disclosed executives at ALX ONCOLOGY HOLDINGS
Jaume Pons, Chief Executive Officer, received $3.7M in total, which decreased by 63% compared to 2021. 54% of Pons' compensation, or $2M, was in option awards. Pons also received $273K in non-equity incentive plan, $584K in salary, as well as $849K in stock awards.
Sophia Randolph, Chief Medical Officer, received a compensation package of $2.1M, which decreased by 56% compared to previous year. 49% of the compensation package, or $1M, was in option awards.
Peter Garcia, Chief Financial Officer, earned $1.8M in 2022, a 63% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 24, 2023.